Evidence map›Paper›PMID 42685016›Full record

ArticlePLOS global public health2026

Newborn screening in Karnataka: A scoping review of the landscape.

Liz Maria Kuriakose, Diwakar Mohan, Mohua Chakraborty Choudhury

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liz Maria KuriakoseDST Center for Policy Research, Indian Institute of Science, Bengaluru, India.ORCID https://orcid.org/0000-0001-6695-0584
Diwakar MohanDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Mohua Chakraborty ChoudhuryDST Center for Policy Research, Indian Institute of Science, Bengaluru, India.ORCID https://orcid.org/0000-0001-6727-9702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newborn screening (NBS) using dried blood spot (DBS) analysis is an important public health intervention to detect serious congenital disorders early, and reduce childhood mortality, and lifelong disabilities. While institutionalized for decades in high-income countries, NBS remains limited in low- and middle-income countries such as India. Despite recommendations in national child healthcare policies, few Indian states have adopted NBS. Even Karnataka, a state performing well in maternal and child health indicators and one of the first states to pilot large-scale NBS studies in the 1980s, is yet to implement a statewide program. This study presents a scoping review of the literature on NBS in Karnataka to understand the NBS efforts so far, identify gaps and provide recommendations for the future. A search of English-language peer-reviewed studies and newspaper articles on newborn/neonatal screening in Karnataka (1980-2024) was conducted using PubMed, Google Scholar, and Google News. Nineteen articles were included, charted using the ISNS framework, and thematically analysed. The results highlighted prevalent themes of research such as disease burden, awareness gaps, inconsistent diagnostic thresholds, consanguinity, lack of data, limited outreach programs, and inadequate NBS facilities. Most studies were hospital-based single-or multi-centre studies limited to the population accessing institutional delivery services. Estimation of incidence and prevalence were the most common research objectives. Diseases commonly considered for screening were inborn errors of metabolism (IEM) and congenital hypothyroidism (CH). A significant burden of CH (ranging from 1:1000) and IEMs (ranging from 1:811) were reported, with certain communities at a higher risk due to prevailing marriage practices. Limited evidence on cost suggests that universal newborn screening is economically feasible, with estimated costs of USD 6.45 per child for a single disorder. All studies support the need for NBS in Karnataka, but further health systems research is needed to inform sustainable implementation.

Identifiers

PMID42685016
PMCPMC13537539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.